Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group

被引:19
作者
Giuliani, Meredith E. [1 ]
Hope, Andrew [1 ]
Mangona, Victor [2 ]
Guckenberger, Matthias [3 ,4 ]
Mantel, Frederick [4 ]
Peulen, Heike [5 ]
Sonke, Jan-Jakob [5 ]
Belderbos, Jose [5 ]
Werner-Wasik, Maria [6 ]
Ye, Hong [2 ]
Grills, Inga S. [2 ]
机构
[1] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[2] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI USA
[3] Univ Zurich, Dept Radiat Oncol, Zurich, Switzerland
[4] Univ Wurzburg, Dept Radiat Oncol, Wurzburg, Germany
[5] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[6] Thomas Jefferson Univ Hosp, Dept Radiat Oncol, Philadelphia, PA 19107 USA
关键词
EBUS; Patterns of failure; SABR; Staging; Stereotactic body radiotherapy; STEREOTACTIC BODY RADIOTHERAPY; TRANSBRONCHIAL NEEDLE ASPIRATION; POSITRON-EMISSION-TOMOGRAPHY; RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; COMPUTED-TOMOGRAPHY; ELDERLY-PATIENTS; POOLED ANALYSIS; CANCER; OUTCOMES;
D O I
10.1016/j.cllc.2016.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study explored the predictors and patterns of regional recurrence (RR) following stereotactic body radiotherapy (SBRT) in 734 cases from a multi-institutional database. The 2-year RR rate was 9%. Stations 4, 7, and 10 were the most common stations for RR following SBRT. These patterns of recurrence may guide nodal staging procedures prior to SBRT. Introduction: The objective of this study was to determine the predictors and patterns of regional recurrence (RR) following stereotactic body radiotherapy (SBRT) for primary lung cancers. Material and Methods: Details of patient factors, treatment, and outcome factors were extracted from a multi-institutional (5) database. All events were calculated from the end of radiotherapy. Estimates of local recurrence, RR, and distant metastases (DM) were calculated using the competing risk method. Cause-specific and overall survival were calculated using the Kaplan-Meier method. Details of locations and number of simultaneous RRs were categorized by lymph node anatomic station. Results: A total of 734 patients were analyzed. The median follow-up was 3.0 years in surviving patients. Four hundred seventy-six (65%) patients had pathologic proof of disease. There were 64 patients with RR. The 2-year local recurrence, RR, and distant metastases rates were 5.6%, 9.0%, and 14.6% respectively. The 2-year cause-specific and overall survival were 89.9% and 63.7%, respectively. There were 136 simultaneous sites of RR. There were 21 recurrences in stations 4R (15.4%), 9 (6.6%) in 4L, 30 (22%) in 7, 19 (13.9%) in 10R, and 14 (10.3%) in 10L. The most common stations for isolated recurrence (n = 19) were station 7 (n = 5; 26.3%) and station 10R (n = 6; 31.6%). The most common RR levels were stations 4 and 7 for right and left upper lobe, stations 5, 7, and 10 for left lower lobe tumors, and stations 7 and 10 for right lower lobe tumors. Conclusion: Stations 4, 7, and 10 were the most common stations for RR. These patterns of recurrence may guide nodal staging procedures prior to SBRT.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 36 条
[1]   The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer [J].
Allibhai, Zishan ;
Taremi, Mojgan ;
Bezjak, Andrea ;
Brade, Anthony ;
Hope, Andrew J. ;
Sun, Alexander ;
Cho, B. C. John .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05) :1064-1070
[2]  
Bezjak A, 2014, RTOG 0813 SEAMLESS P
[3]   Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections [J].
Boffa, Daniel J. ;
Kosinski, Andrzej S. ;
Paul, Subroto ;
Mitchell, John D. ;
Onaitis, Mark .
ANNALS OF THORACIC SURGERY, 2012, 94 (02) :347-353
[4]   Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Chang, Joe Y. ;
Senan, Suresh ;
Paul, Marinus A. ;
Mehran, Reza J. ;
Louie, Alexander V. ;
Balter, Peter ;
Groen, Harry J. M. ;
McRae, Stephen E. ;
Widder, Joachim ;
Feng, Lei ;
van den Borne, Ben E. E. M. ;
Munsell, Mark F. ;
Hurkmans, Coen ;
Berry, Donald A. ;
van Werkhoven, Erik ;
Kresl, John J. ;
Dingemans, Anne-Marie ;
Dawood, Omar ;
Haasbeek, Cornelis J. A. ;
Carpenter, Larry S. ;
De Jaeger, Katrien ;
Komaki, Ritsuko ;
Slotman, Ben J. ;
Smit, Egbert F. ;
Roth, Jack A. .
LANCET ONCOLOGY, 2015, 16 (06) :630-637
[5]   Predictive Factors for Node Metastasis in Patients With Clinical Stage I Non-Small Cell Lung Cancer [J].
Cho, Sukki ;
Song, In Hag ;
Yang, Hee Chul ;
Kim, Kwhanmien ;
Jheon, Sanghoon .
ANNALS OF THORACIC SURGERY, 2013, 96 (01) :239-245
[6]   Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome? [J].
Clarke, Katy ;
Taremi, Mojgan ;
Dahele, Max ;
Freeman, Marc ;
Fung, Sharon ;
Franks, Kevin ;
Bezjak, Andrea ;
Brade, Anthony ;
Cho, John ;
Hope, Andrew ;
Sun, Alexander .
RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) :62-66
[7]   The role of endobronchial ultrasound/esophageal ultrasound for evaluation of the mediastinum in lung cancer [J].
Czarnecka, Kasia ;
Yasufuku, Kazuhiro .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (06) :763-776
[8]   Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer [J].
Dahele, Max ;
Palma, David ;
Lagerwaard, Frank ;
Slotman, Ben ;
Senan, Suresh .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :1221-1228
[9]  
Eapen G.A., 2016, ADDITIVE VALUE ENDOB
[10]   Efficacy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Hilar Lymph Nodes for Diagnosing and Staging Cancer [J].
Ernst, Armin ;
Eberhardt, Ralf ;
Krasnik, Mark ;
Herth, Felix J. F. .
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (08) :947-950